ABBV vs DGX
By Alex · Tickerpine
AbbVie Inc. vs Quest Diagnostics Incorporated, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | DGX |
|---|---|---|
| Price | $285.64 | $241.89 |
| Market cap | $504.76B | $26.70B |
| P/E ratio | 80.5 | 24.1 |
| ROE | — | 15.32% |
| Profit margin | 9.80% | 9.54% |
| Revenue growth | 10.20% | 10.00% |
| Dividend yield | 2.42% | 1.42% |
| Beta | 0.23 | — |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs DGX in plain English
- ABBV is the bigger company — about 18.9× the market cap of DGX.
- DGX is cheaper on earnings (P/E 24.1 vs 80.5).
- ABBV is growing revenue faster (10% vs 10%).
- ABBV has the higher dividend yield (2.42% vs 1.42%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
DGX return calculator
See what $1,000 in Quest Diagnostics Incorporated would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.